Specialist healthcare investor GHO Capital has bought RoslinCT, a contract development and management organisation spinout focused on advanced cell therapies.
Selling investors have made returns of 6x their original investment in the precision parts producer
Costa Yiannoulis and David Welch spoke to Unquote about the food technology and alternative protein VC's strategy
Buyer's PE arm competed with Bain and Cinven in the auction second round
Eimear Palmer joins Pantheon from ICG, which has poached Elsa Palanza from Barclays